1. Investment Snapshot
2. Thesis
3. Valuation & Price Target
4. Business & Product Moat
5. People & Governance
6. Market & Macro
7. Financial Quality
8. Risk Register
9. Prediction Market
10. π Posts
Discussion
1. Investment Snapshot
2. Thesis
3. Valuation & Price Target
4. Business & Product Moat
5. People & Governance
6. Market & Macro
7. Financial Quality
8. Risk Register
9. Prediction Market
10. π Posts
Discussion
1. Investment Snapshot
2. Capital Structure
3. What does Lincoln International, Inc. do?
4. Valuation
5. Business & Product Moat
6. People & Governance
7. Financial Quality
8. Prediction Market
9. π Posts
Discussion
Symbol
LCLN
Event Date
2026-05-20
Sector
Financials
Subsector
Capital Markets
Offer Range
β
Shares Offered
21.05M
Shares Outstanding Pre-IPO
11.05M
101.98M
β
Implied Upside vs Midpoint
$00.00Description
**Valuation Verdict:** Lincoln screens like a midβmarket advisory platform with a meaningful portfolioβvaluation revenue stream that should soften cyclicality versus pure transaction boutiques. That defensiveness helps support a valuation floor, but multiβclass control and ongoing TRA cash outflows are real, likely persistent headwinds for governanceβsensitive investors. Netting those factors, the setup looks fair to modestly discounted versus midβmarket advisory comps rather than a premium multiple candidate. **Catalyst Timeline:** The next 12β24 months are about execution: using proceeds for unit redemptions and termβloan paydown, then showing that a lower interest burden translates into cleaner earnings. Integration followβthrough from MarshBerry (closed Oct 31, 2025) is the other swing factor; any crossβsell or cost capture should show up over several quarters. Reβrating will hinge on clearer TRA payment dynamics and early postβIPO capitalβallocation decisions. **Growth & Margin Trajectory:** Growth should come from incremental share gains in midβmarket advisory plus deeper penetration of the portfolioβvaluation franchise. Managementβs scale indicators (>25,000 valuations in 2025 and ~32% coverage of U.S. PEβbacked companies) support the case that valuations can dampen cycle volatility even if M&A fees stay episodic. Near term, acquisitionβrelated costs and interest expense can pressure margins until debt is reduced; over a normalized cycle, modest growth with stableβtoβimproving margins is a reasonable base case. **Governance & Operational Risk:** Control is concentrated: controlling partners retain ~87% voting power postβoffering, limiting minority influence and potentially capping the multiple regardless of operating performance. The business remains peopleβdependent, with senior banker retention and privateβequity client concentration as central risks. The TRA (85% of certain tax benefits payable) is a structural cash claim that can compete with reinvestment and shareholder returns. **Scenario Targets:** Base case: a steady operating tape with improving net interest expense supports gradual multiple expansion as governance/TRA concerns become better quantified; Target: $18β$25 per share over 12β24 months, contingent on normalized deal flow and clearer TRA impact. Upside case: sponsorβled activity rebounds and acquisition integration adds measurable operating leverage, supporting a premium to midβmarket peers. Downside case: a prolonged M&A lull plus heavierβthanβexpected TRA drag and persistent governance discount pushes the stock below the IPO level.
β
Global independent advisory with ~1,400 professionals across 30+ officesβ
Fee-for-service model with a meaningful recurring valuation component to reduce cyclicalityPost-IPO economic shares by class.
| Class | Shares | % Economic |
|---|---|---|
Class A Common Stock (listed) 1 vote per share Β· One-to-one exchange for common units held by Company (maintained 1:1 ratio with common units owned by Company) | 31.66M | 31.0% |
Class B Common Stock 1 vote per share Β· Cancelled on redemption/exchange of corresponding common units; may be exchanged/converted 1-for-1 as provided under partnership/corporate documents | 28.94M | 28.4% |
Class C Common Stock 10 votes per share Β· Exchangeable 1-for-1 into Class A or Class B common stock per governing documents; Class C is convertible to Class A or Class B at one-to-one under specified conditions | 41.39M | 40.6% |
| Total economic shares | 101.98M | 100% |
Lincoln screens like a midβmarket advisory platform with a meaningful portfolioβvaluation revenue stream that should soften cyclicality versus pure transaction boutiques. That defensiveness helps support a valuation floor, but multiβclass control and ongoing TRA cash outflows are real, likely persistent headwinds for governanceβsensitive investors. Netting those factors, the setup looks fair to modestly discounted versus midβmarket advisory comps rather than a premium multiple candidate.
The next 12β24 months are about execution: using proceeds for unit redemptions and termβloan paydown, then showing that a lower interest burden translates into cleaner earnings. Integration followβthrough from MarshBerry (closed Oct 31, 2025) is the other swing factor; any crossβsell or cost capture should show up over several quarters. Reβrating will hinge on clearer TRA payment dynamics and early postβIPO capitalβallocation decisions.
Growth should come from incremental share gains in midβmarket advisory plus deeper penetration of the portfolioβvaluation franchise. Managementβs scale indicators (>25,000 valuations in 2025 and ~32% coverage of U.S. PEβbacked companies) support the case that valuations can dampen cycle volatility even if M&A fees stay episodic. Near term, acquisitionβrelated costs and interest expense can pressure margins until debt is reduced; over a normalized cycle, modest growth with stableβtoβimproving margins is a reasonable base case.
Control is concentrated: controlling partners retain ~87% voting power postβoffering, limiting minority influence and potentially capping the multiple regardless of operating performance. The business remains peopleβdependent, with senior banker retention and privateβequity client concentration as central risks. The TRA (85% of certain tax benefits payable) is a structural cash claim that can compete with reinvestment and shareholder returns.
Base case: a steady operating tape with improving net interest expense supports gradual multiple expansion as governance/TRA concerns become better quantified; Target: $18β$25 per share over 12β24 months, contingent on normalized deal flow and clearer TRA impact. Upside case: sponsorβled activity rebounds and acquisition integration adds measurable operating leverage, supporting a premium to midβmarket peers. Downside case: a prolonged M&A lull plus heavierβthanβexpected TRA drag and persistent governance discount pushes the stock below the IPO level.
+
Sector specialization and global presence support sponsor relationships and repeat mandatesβ
Portfolio valuations can dampen transaction-driven cyclicalityβ
Deleveraging is the clearest near-term path to cleaner earningsβ
Governance control and TRA economics are the primary non-operating overhangsβ
Governance concentration and TRA payments are the central drivers of any structural discountβ
External commentary cites ~11x trailing P/E (fully diluted) versus peers around ~20x+
CEO with 28 years at the firm and deep sponsor relationshipsβ
Talent retention remains a principal risk in a people-driven modelβ
Founder leadership presence supports continuityβ
Independent directors provide governance and audit oversightβ
2025 revenue of $783.8 million and net income of $214.1 millionβ
~25,000 valuations in 2025 support a steadier revenue base within a cyclical modelβ
Q1 2026 profitability was lower, reflecting transaction timing variabilityβ
Term-loan leverage includes $250 million plus a $24.9 million delayed draw loan; planned repayment should lower interest expenseLoading distributionβ¦
Posts argue the company looks inexpensive versus peers and highlight confidence in the team and midβmarket positioning, with some noting a muted early trading debut.
AI per-post analysis: 4 positive, 0 negative, 6 neutral (engagement-weighted aggregate).